Twitter

Link your Twitter Account to Market Wire News


When you linking your Twitter Account Market Wire News Trending Stocks news and your Portfolio Stocks News will automatically tweet from your Twitter account.


Be alerted of any news about your stocks and see what other stocks are trending.



home / news releases / PFE - Prometheus Biosciences: Precision Medicine For IBD


PFE - Prometheus Biosciences: Precision Medicine For IBD

  • Prometheus has built the leading platform and data set for IBD drug development that has enabled partnerships, a diverse pipeline, and non-dilutive capital.
  • IBD is a market opportunity representing millions of patients, which has had little innovation over the last 2 decades.
  • The company has an upcoming catalyst with Phase 1 data coming out for their lead asset over the next few months, which can set up a Phase 2 clinical trial.

For further details see:

Prometheus Biosciences: Precision Medicine For IBD
Stock Information

Company Name: Pfizer Inc.
Stock Symbol: PFE
Market: NYSE
Website: pfizer.com

Menu

PFE PFE Quote PFE Short PFE News PFE Articles PFE Message Board
Get PFE Alerts

News, Short Squeeze, Breakout and More Instantly...